Company News for Apr 24, 2020

Zacks Equity Research Published on April 24, 2020

Shares of Eli Lilly and Company (LLY - Free Report) surged 2.1% after the company reported first-quarter 2020 adjusted earnings of $1.75 per share, which beat the Zacks Consensus Estimate of $1.55.
Shares of Cassava Sciences, Inc. (SAVA - Free Report) soared 32% after the company announced a $2.5 million research grant win from the National Institutes of Health.
Shares of Fluor Corporation (FLR - Free Report) gained 8.8% after the company won an 8-year contract beginning in May 2020 on the Air Force Contract Augmentation Program V.
Shares of LSI Industries Inc. (LYTS - Free Report) rose 11.5% after the company posted revenues of $71.01 million for the quarter ended March 2020, outpacing the Zacks Consensus Estimate by 0.04%.

Zacks Names "Single Best Pick to Double"

From thousands of stocks, 5 Zacks experts each have chosen their favorite to skyrocket +100% or more in months to come. From those 5, Director of Research Sheraz Mian hand-picks one to have the most explosive upside of all.

It’s a little-known chemical company that’s up 65% over last year, yet still dirt cheap. With unrelenting demand, soaring 2022 earnings estimates, and $1.5 billion for repurchasing shares, retail investors could jump in at any time.

This company could rival or surpass other recent Zacks’ Stocks Set to Double like Boston Beer Company which shot up +143.0% in little more than 9 months and NVIDIA which boomed +175.9% in one year.